drugset
drugset / Trial / NCT03532854

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

NCT03532854 ↗

Phase 1 Completed 42 enrolled LG Chem
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the drug-drug interaction between LGEV1801 and LGEV1802 in healthy male volunteers.

Timeline

Start
2018-05-28
Primary completion
2018-08-25
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe/Rosuvastatin Unknown — Oral
Subject Valsartan Small molecule — Oral

Indications

No indication recorded.